Skip to main content
. Author manuscript; available in PMC: 2021 Oct 27.
Published in final edited form as: Int J Cancer. 2019 Nov 22;147(1):45–55. doi: 10.1002/ijc.32707

Table 4.

Pooled odds ratios (ORs) and 95% confidence intervals (CIs) of gastric cancer for the highest compared to the lowest study-specific tertile of different sources of meat in strata of selected variables.

White Meat Red Meat Processed Meat Total Meat

OR (95% CI) [1] I2 (%) OR (95% CI) [1] I2 (%) OR (95% CI) [1] I2 (%) OR (95% CI) [1] I2 (%)

Overall 1.09 (0.93–1.26) 56.4 1.24 (1.00–1.53) 82.3 1.23 (1.06–1.43) 60.2 1.30 (1.09–1.55) 77.9
Sex
 Men 1.00 (0.89–1.13) 5.4 1.19 (0.97–1.46) 65.6 1.21 (1.05–1.38) 26.4 1.23 (1.05–1.45) 52.3
 Women 1.27 (0.94–1.70) 67.4 1.28 (0.96–1.69) 69.0 1.29 (0.99–1.68) 64.0 1.41 (1.06–1.86) 72.4
P for interaction 0.146 0.690 0.656 0.421
Age (years)
 ≤55 1.04 (0.86–1.27) 14.5 1.05 (0.78–1.42) 62.6 1.39 (1.18–1.63) 2.1 1.10 (0.90–1.35) 35.0
 >55 to ≤65 1.19 (0.93–1.54) 42.2 1.26 (0.95–1.66) 60.6 1.19 (0.93–1.53) 46.0 1.44 (1.10–1.88) 61.0
 >65 0.97 (0.83–1.14) 12.4 1.38 (1.09–1.75) 59.9 1.13 (0.92–1.39) 45.2 1.33 (1.07–1.67) 58.2
P for interaction 0.389 0.364 0.265 0.238
Area
 Europe 1.15 (0.88–1.52) 72.2 1.27 (0.91–1.78) 81.4 1.28 (1.02–1.60) 55.3 1.42 (1.06–1.89) 72.1
 Asia 0.97 (0.72–1.30) 60.0 0.94 (0.59–1.51) 87.3 0.98 (0.80–1.20) 27.3 1.01 (0.74–1.38) 81.1
 Americas 1.07 (0.86–1.33) 0.0 1.49 (1.01–2.20) 76.7 1.45 (1.14–1.84) 42.4 1.51 (1.09–2.08) 66.6
P for interaction 0.700 0.330 0.038 0.159
Socioeconomic status [2]
 Low 1.19 (0.91–1.57) 61.1 1.33 (1.04–1.70) 61.5 1.25 (1.00–1.55) 47.4 1.33 (1.09–1.63) 47.6
 Intermediate 0.91 (0.73–1.13) 14.1 1.13 (0.81–1.58) 66.4 1.25 (0.95–1.63) 49.9 1.28 (0.95–1.74) 62.5
 High 1.10 (0.79–1.53) 0.0 0.99 (0.57–1.71) 62.4 1.34 (0.96–1.86) 15.8 1.20 (0.80–1.82) 51.6
P for interaction 0.280 0.540 0.934 0.903
Smoking status
 Never 1.24 (0.97–1.59) 63.2 1.29 (0.99–1.69) 72.4 1.18 (0.93–1.49) 60.1 1.33 (1.04–1.69) 70.5
 Former 1.01 (0.85–1.19) 0.0 1.28 (1.08–1.52) 4.3 1.31 (1.06–1.62) 24.1 1.32 (1.14–1.53) 0.7
 Current 0.89 (0.72–1.11) 14.3 1.04 (0.76–1.41) 55.3 1.10 (0.93–1.30) 0.0 1.08 (0.88–1.32) 26.5
P for interaction 0.138 0.458 0.446 0.238
Alcohol drinking
 Non-drinker 1.17 (0.97–1.46) 33.4 1.31 (0.97–1.75) 72.2 1.24 (1.02–1.50) 32.3 1.34 (1.05–1.73) 66.6
 Drinker
 Low (≤12 g/day) 1.19 (0.88–1.59) 50.2 1.10 (0.79–1.53) 67.7 1.32 (0.97–1.81) 60.5 1.26 (0.92–1.72) 68.1
 Intermediate (>12–47 g/day) 0.90 (0.70–1.15) 15.3 1.23 (0.98–1.53) 13.4 0.98 (0.75–1.28) 32.0 1.20 (1.02–1.39) 0.0
 High (>47 g/day) 0.96 (0.57–1.61) 36.5 1.03 (0.65–1.63) 31.7 1.54 (1.12–2.12) 0.0 1.42 (1.06–1.91) 0.0
P for interaction 0.312 0.792 0.175 0.642
Controls
 Hospital-based[3] 1.05 (0.87–1.26) 17.3 1.51 (1.09–2.11) 76.4 1.31 (1.03–1.66) 54.0 1.42 (1.08–1.86) 72.6
 Population-based[4] 1.10 (0.89–1.40) 72.5 1.05 (0.80–1.38) 84.8 1.17 (0.96–1.44) 68.1 1.20 (0.94–1.53) 81.8
P for interaction 0.687 0.096 0.505 0.372
Site [5]
 Cardia 1.30 (0.96–1.75) 15.8 1.61 (0.99–2.63) 69.0 1.34 (0.97–1.84) 29.3 1.76 (1.15–2.70) 59.5
 Non-cardia 1.11 (0.95–1.30) 53.8 1.28 (1.03–1.59) 78.7 1.24 (1.03–1.49) 68.3 1.34 (1.11–1.62) 74.9
P for interaction 0.370 0.406 0.676 0.255
Histological type [6]
 Intestinal 1.19 (0.91–1.55) 48.9 1.67 (1.04–2.66) 81.9 1.17 (0.84–1.65) 66.2 1.50 (1.06–2.13) 73.8
 Diffuse 1.28 (1.03–1.58) 11.0 1.34 (0.91–1.98) 63.4 1.44 (1.16–1.80) 12.4 1.46 (1.12–1.90) 46.1
 Undifferentiated 1.33 (0.84–2.09) 55.3 1.56 (0.85–2.87) 69.6 1.23 (0.87–1.74) 50.7 1.57 (0.98–2.53) 61.7
P for interaction 0.883 0.770 0.532 0.964
Vegetables and fruits intake
 Low 1.04 (0.83–1.30) 17.4 1.02 (0.79–1.33) 49.9 1.33 (1.04–1.71) 43.6 1.12 (0.90–1.38) 39.1
 Intermediate 0.97 (0.83–1.12) 0.0 1.29 (1.02–1.62) 44.3 1.23 (1.00–1.52) 34.9 1.32 (1.07–1.63) 44.5
 High 1.23 (0.99–1.53) 40.3 1.23 (0.89–1.71) 75.8 1.16 (0.92–1.45) 50.5 1.38 (1.02–1.88) 75.0
P for interaction 0.188 0.413 0.711 0.418
Family history of GC [7]
 No 1.12 (0.91–1.37) 62.0 1.36 (1.01–1.85) 85.2 1.11 (0.90–1.36) 60.7 1.31 (1.04–1.67) 79.2
 Yes 1.16 (0.91–1.48) 0.0 1.19 (0.68–2.07) 77.9 1.30 (0.84–1.99) 37.2 1.56 (0.83–2.93) 68.9
P for interaction 0.824 0.671 0.518 0.626
Body Mass Index (BMI) (kg/m2)
 <18.5 0.56 (0.14–2.27) 60.9 1.76 (0.66–4.73) 43.7 0.94 (0.25–3.56) 55.2 0.97 (0.62–1.53) 0.7
 18.5–25 1.00 (0.86–1.15) 5.7 1.24 (1.01–1.52) 43.0 1.15 (0.89–1.50) 64.1 1.29 (1.01–1.66) 70.2
 25–30 1.03 (0.75–1.42) 59.0 1.15 (0.84–1.58) 61.7 1.46 (1.18–1.81) 22.8 1.28 (1.01–1.63) 42.3
 >30 1.50 (0.83–2.69) 65.8 1.37 (0.73–2.59) 58.9 1.37 (0.98–1.91) 0.0 1.51 (1.02–2.22) 36.0
P for interaction 0.485 0.852 0.530 0.553
Studies with information on total energy intake [7]
 Adjusting for energy 1.02 (0.82–1.26)  63.0 1.06 (0.84–1.33)  68.9 1.16 (1.00–1.35) 35.9 1.22 (1.06–1.41) 35.7
 Not-adjusting for energy 1.06 (0.86–1.31)  64.4 1.22 (0.95–1.56)  77.8 1.31 (1.10–1.56) 54.9 1.36 (1.13–1.63) 64.3
Studies with information on H. pylori (HP) infection [8]
 Adjusting for HP 1.22 (0.92–1.62) 60.3 1.29 (0.77–2.17) 89.7 1.15 (0.91–1.46) 44.6 1.35 (0.93–1.96) 82.6
 Not-adjusting for HP 1.21 (0.91–1.60) 66.0 1.25 (0.76–2.04) 89.9 1.15 (0.88–1.49) 61.3 1.28 (0.89–1.82) 84.5
[1]

Pooled ORs were computed using random-effects models, which included, when available and applicable, terms for sex, age (5-year age groups: <40;40–44; …; 70–74; ≥75), socioeconomic status (low, intermediate, or high, as defined in each original study based on education, income or occupation), smoking status (never, former and current smokers of ≤10 cigarettes/day; 11 to 20 cigarettes/day; >20 cigarettes/day), alcohol drinking (never, low: ≤12 g of ethanol/day, intermediate: >12 to 47 g of ethanol/day, high: >47 g of ethanol/day), fruits and vegetables consumption (study-specific tertiles), total energy intake (study-specific quintiles), study center (for multicenter studies), and race/ethnicity (“White”, “Black/African American”, “Asian”, “Hispanic/Latino”, “Other”, family history of gastric cancer and body mass categories (<18.5; 18.5–25; 25–30; >30 kg/m2).

[2]

No information for the study Japan 2.23 As defined in each original study based on education, income or occupation.

[3]

Includes studies Brazil 1,13 Brazil 2,12 Greece,17 Italy 1,19 Italy 2,20 Italy 3,21 Japan 1,24 Japan 2,25 Japan 3,23 Mexico 3,27 Russia30 and Spain 2.32

[4]

Includes studies Canada,14 China 2,15 China 3,16 Iran 1,18 Italy 4,22 Mexico 1,26 Mexico 2,28 Portugal29 and Spain 1.31

[5]

Excluding studies China 2,15 China 316 and Mexico 3.27

[6]

Excluding studies China 2,15 Greece,17 Italy 1,19 Japan 2,25 Japan 323 and Mexico 2.28

[7]

No information for studies Canada,14 Russia,30 Iran 1,18 Japan 2,23 Brazil 113 and Brazil 2.12

[8]

H. pylori infection was defined using the same criteria of the original studies, according to the following serological tests: enzyme-linked immunosorbent assay (ELISA) tests (9 studies)12, 13, 18, 23, 24, 26, 27, 29, 30 to determine immunoglobulin G (IgG) antibody titers in serum, and in one study through multiplex serology.31 When anti-H. pylori serum IgG titers were assessed using an ELISA-based method, participants with borderline results were classified as testing positive for H. pylori infection.